Skip to main content
Journal cover image

High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.

Publication ,  Journal Article
Blanchard, SK; Sullivan, KM; Hooten, JN; Holcomb, ZE; Rowe Nichols, K; Selim, MA; Rao, CL; Hall, RP; Chao, NJ; Cardones, AR
Published in: Br J Dermatol
October 2019

Duke Scholars

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

October 2019

Volume

181

Issue

4

Start / End Page

869 / 871

Location

England

Related Subject Headings

  • Treatment Outcome
  • Transplantation, Homologous
  • Skin Diseases
  • Skin
  • Severity of Illness Index
  • Middle Aged
  • Male
  • Immunoglobulins, Intravenous
  • Humans
  • Hematopoietic Stem Cell Transplantation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blanchard, S. K., Sullivan, K. M., Hooten, J. N., Holcomb, Z. E., Rowe Nichols, K., Selim, M. A., … Cardones, A. R. (2019). High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol, 181(4), 869–871. https://doi.org/10.1111/bjd.18028
Blanchard, S. K., K. M. Sullivan, J. N. Hooten, Z. E. Holcomb, K. Rowe Nichols, M. A. Selim, C. L. Rao, R. P. Hall, N. J. Chao, and A. R. Cardones. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.Br J Dermatol 181, no. 4 (October 2019): 869–71. https://doi.org/10.1111/bjd.18028.
Blanchard SK, Sullivan KM, Hooten JN, Holcomb ZE, Rowe Nichols K, Selim MA, et al. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol. 2019 Oct;181(4):869–71.
Blanchard, S. K., et al. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.Br J Dermatol, vol. 181, no. 4, Oct. 2019, pp. 869–71. Pubmed, doi:10.1111/bjd.18028.
Blanchard SK, Sullivan KM, Hooten JN, Holcomb ZE, Rowe Nichols K, Selim MA, Rao CL, Hall RP, Chao NJ, Cardones AR. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol. 2019 Oct;181(4):869–871.
Journal cover image

Published In

Br J Dermatol

DOI

EISSN

1365-2133

Publication Date

October 2019

Volume

181

Issue

4

Start / End Page

869 / 871

Location

England

Related Subject Headings

  • Treatment Outcome
  • Transplantation, Homologous
  • Skin Diseases
  • Skin
  • Severity of Illness Index
  • Middle Aged
  • Male
  • Immunoglobulins, Intravenous
  • Humans
  • Hematopoietic Stem Cell Transplantation